Safety and Immunogenicity of a Proteosome-Shigella flexneri 2a Lipopolysaccharide Vaccine Administered Intranasally to Healthy Adults

Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue IAI About IAI Subscribers Authors Reviewers Advertisers Inquiries from the...

Full description

Saved in:
Bibliographic Details
Published inInfection and Immunity Vol. 69; no. 7; pp. 4545 - 4553
Main Authors Fries, Louis F., Montemarano, Andrew D., Mallett, Corey P., Taylor, David N., Hale, Thomas L., Lowell, George H.
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.07.2001
Subjects
Online AccessGet full text
ISSN0019-9567
1098-5522
DOI10.1128/IAI.69.7.4545-4553.2001

Cover

More Information
Summary:Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue IAI About IAI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy Connect to IAI IAI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0019-9567 Online ISSN: 1098-5522 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to IAI .asm.org, visit: IAI       
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Present address: 92 High St., Medford, MA 02155.
Corresponding author. Mailing address: Intellivax, Inc., UMBC Technology Center, 1450 South Rolling Rd., Baltimore, MD 21227. Phone: (410) 455-5610. Fax: (410) 455-5606. E-mail: lfries@intellivax.com.
ISSN:0019-9567
1098-5522
DOI:10.1128/IAI.69.7.4545-4553.2001